These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31413870)

  • 41. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
    Haschka J; Englbrecht M; Hueber AJ; Manger B; Kleyer A; Reiser M; Finzel S; Tony HP; Kleinert S; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Wendler J; Schuch F; Ronneberger M; Lorenz HM; Nuesslein H; Alten R; Demary W; Henes J; Schett G; Rech J
    Ann Rheum Dis; 2016 Jan; 75(1):45-51. PubMed ID: 25660991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis.
    Hetland ML; Hørslev-Petersen K
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S44-9. PubMed ID: 23079125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
    Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
    Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment algorithm for rheumatoid arthritis : According to the S2e guidelines 2018].
    Fiehn C; Krüger K
    Z Rheumatol; 2019 Aug; 78(6):529-539. PubMed ID: 31297605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis.
    Hazlewood GS; Barnabe C; Tomlinson G; Marshall D; Devoe D; Bombardier C
    BMJ; 2016 Apr; 353():i1777. PubMed ID: 27102806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defining and characterizing sustained remission in patients with rheumatoid arthritis.
    Curtis JR; Trivedi M; Haraoui B; Emery P; Park GS; Collier DH; Aras GA; Chung J
    Clin Rheumatol; 2018 Apr; 37(4):885-893. PubMed ID: 29224127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.
    Schett G; Emery P; Tanaka Y; Burmester G; Pisetsky DS; Naredo E; Fautrel B; van Vollenhoven R
    Ann Rheum Dis; 2016 Aug; 75(8):1428-37. PubMed ID: 27261493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).
    Kaneko Y; Kato M; Tanaka Y; Inoo M; Kobayashi-Haraoka H; Amano K; Miyata M; Murakawa Y; Yasuoka H; Hirata S; Tanaka E; Miyasaka N; Yamanaka H; Yamamoto K; Takeuchi T;
    Ann Rheum Dis; 2018 Sep; 77(9):1268-1275. PubMed ID: 29853455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment Guidelines in Rheumatoid Arthritis.
    Singh JA
    Rheum Dis Clin North Am; 2022 Aug; 48(3):679-689. PubMed ID: 35953230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis and Management of Rheumatoid Arthritis: A Review.
    Aletaha D; Smolen JS
    JAMA; 2018 Oct; 320(13):1360-1372. PubMed ID: 30285183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug therapy in undifferentiated arthritis: a systematic literature review.
    Wevers-de Boer KV; Heimans L; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2013 Sep; 72(9):1436-44. PubMed ID: 23744979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?
    Levesque MC
    BioDrugs; 2012 Apr; 26(2):65-70. PubMed ID: 22385403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
    Mary J; De Bandt M; Lukas C; Morel J; Combe B
    J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration.
    Kita J; Tamai M; Arima K; Nakashima Y; Suzuki T; Kawashiri SY; Iwamoto N; Okada A; Koga T; Yamasaki S; Nakamura H; Origuchi T; Ida H; Aoyagi K; Uetani M; Eguchi K; Kawakami A
    Mod Rheumatol; 2012 Jun; 22(3):346-52. PubMed ID: 21960457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in routine care.
    Burgers LE; van der Pol JA; Huizinga TWJ; Allaart CF; van der Helm-van Mil AHM
    Arthritis Res Ther; 2019 May; 21(1):115. PubMed ID: 31064384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Chatzidionysiou K; Emamikia S; Nam J; Ramiro S; Smolen J; van der Heijde D; Dougados M; Bijlsma J; Burmester G; Scholte M; van Vollenhoven R; Landewé R
    Ann Rheum Dis; 2017 Jun; 76(6):1102-1107. PubMed ID: 28356243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission.
    Kuriya B; Arkema EV; Bykerk VP; Keystone EC
    Ann Rheum Dis; 2010 Jul; 69(7):1298-304. PubMed ID: 20421343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations.
    Koike T
    J Orthop Sci; 2015 Nov; 20(6):951-7. PubMed ID: 26404390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methotrexate in rheumatoid arthritis.
    Swierkot J; Szechiński J
    Pharmacol Rep; 2006; 58(4):473-92. PubMed ID: 16963793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.